Update on the Management and Monitoring of Deep Analgesia and Sedation in the Intensive Care Unit
Gina Pettineo Riggi, PharmD; Maresa Glass, PharmD, BCPS
Update on the Management and Monitoring of Deep Analgesia and Sedation in the Intensive Care Unit: Read Article
Get CNE

Learning Objectives

At the completion of this program, you will be able to:
  • Identify potential pharmacological agents for stress, anxiety, and pain in the adult intensive care unit (ICU) population.
  • Describe objective assessment and monitoring recommendations for sedation and analgesia.
  • Discuss pharmacodynamics, as well as advantages and disadvantages of various agents used in the adult ICU for the initiation and maintenance of sedation and analgesia.

Continuing Education Information

CE ID: ACC332
Total Contact Hours: 1.00
Pharma Hours: 1.00
Synergy Cat: A
Test Expires: 4/1/2016

Description

Publication/Sponsor Information


All rights reserved. No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. Permission to photocopy articles: This publication is protected by copyright. Permission to photocopy must be secured in writing from: Permissions Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106-3621; fax: 215-521-8466 or Copyright Clearance Center CCC, 222 Rosewood Dr., Danvers, MA 01923; phone: 978-750-8400; fax: 978-750-4470; www.copyright.com.

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.

Your Feedback